The treatment of serum-deprived wild-type NIH3T3 cells with MG132 resulted in an increased PCD (Fig. 3B) supporting our hypothesis. To test whether MG132 treatment affects PCD due to the inhibition of the ciliary proteasome or due to the inhibition of the overall cellular proteasomal activity, we treated serum-deprived Rpgrip1l-/-NIH3T3 cells with MG132. We found that the percentage of CC3-positive Rpgrip1l-/- NIH3T3 cells was not increased by the treatment with MG132
Curious what the ciliation levels are in MG132 treated serum starved cells in these experiments. There is a difference between ciliation percentage in the RPGRIP1l mutants vs wild type as in Figure 1C which also show a different percentage of CC3+ PCD in figure 1D but perhaps no difference in CC3+ PCD between the mutant and wild-type (RPGRIP1l +/+ w MG132 and RPGRIP1l -/- w MG132) in the presence of MG132 (though these are not shown on the same graph and perhaps not done in the same experiment?)